| 1 |
贾晶晶, 唐西怀, 殷娟. 慢性阻塞性肺疾病患者肺部感染的病原学及危险因素研究[J]. 临床肺科杂志, 2019, 24 (3) : 477-480.
|
| 2 |
宋玉龙, 侯伟, 金茜. 慢性阻塞性肺疾病患者急性加重期合并肺部感染的病原菌分布及危险因素分析[J]. 工业卫生与职业病, 2019, 45 (3) : 227-228, 231.
|
| 3 |
DanielsJM, SnijdersD, de GraaffCS,et al.Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2010,181 (2):150-157.
|
| 4 |
刘延一, 杨俊华, 叶丹. 慢性阻塞性肺病急性加重患者呼吸道多重耐药菌感染危险因素分析[J]. 临床肺科杂志, 2019, 24 (4) : 661-664.
|
| 5 |
BergJ, HalvorsenAR, BengtsonMB,et al.Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease[J].BMC Cancer,2018,18 (1):739.
|
| 6 |
廖小雯, 陈玉梅, 汤玉蓉, 等. COPD患者并发真菌感染的临床特点、危险因素及治疗效果分析[J]. 中国病原生物学杂志, 2019, 14 (4) : 452-455.
|
| 7 |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版) [J]. 中华结核和呼吸杂志, 2013, 36 (4) : 255-264.
|
| 8 |
尚红, 王毓三, 申子瑜. 全国临床检验操作规程[M]. 北京: 人民卫生出版社, 2015: 109-111.
|
| 9 |
ChernetskaNV, StupnytskaHY, FedivOI.The role of MDR1 (C3435T) gene polymorphism in patients with chronic obstructive pulmonary disease associated with type 2 diabetes mellitus[J].J Med Life,2020,13 (3):349-355.
|
| 10 |
王朝霞. 慢性阻塞性肺疾病急性加重患者的病原菌分布和耐药性分析[J]. 贵州医药, 2019, 43 (9) : 1398-1399.
|
| 11 |
李娜, 王美霞, 周晋萌, 等. 维生素D对脓毒性休克导致急性呼吸窘迫综合征患者的干预价值研究[J/CD]. 中华危重症医学杂志(电子版) , 2020, 13 (5) : 321-327.
|
| 12 |
Kuznar-KamińskaB, Mikula-PietrasikJ, MalyE,et al.Serum from patients with chronic obstructive pulmonary disease promotes proangiogenic behavior of the vascular endothelium[J].Eur Rev Med Pharmacol Sci,2018,22 (21):7470-7481.
|
| 13 |
王婷, 赵丹, 张冀军, 等. 慢性阻塞性肺疾病患者血清淀粉样蛋白A、颗粒蛋白前体的表达及临床意义[J]. 中华生物医学工程杂志, 2021, 27 (2) : 201-204.
|
| 14 |
胡诗礼, 李丽华, 张李, 等. 血清IL-17和CHE及和肽素水平与老年COPD合并肺部感染的相关性[J]. 中华医院感染学杂志, 2020, 30 (21) : 3272-3276.
|
| 15 |
ShpaginaLA, KamnevaNV, KudelyaLM,et al.Diagnostic and prognostic markers of chronic heart failure in patients with occupational chronic obstructive pulmonary disease[J].Kardiologiia,2020,60 (7):44-52.
|
| 16 |
尹小华, 甘学琴. COPD患者WBC、CRP、PCT水平变化及其临床意义[J]. 检验医学与临床, 2019, 16 (11) : 1567-1569.
|
| 17 |
HiraiK, ShiraiT, SuzukiM,et al.A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype[J].Clin Exp Allergy,2017,47 (11):1374-1382.
|
| 18 |
何雪, 李窕, 彭雅婷, 等. 慢性阻塞性肺疾病的血清标志物研究进展[J]. 中国医师杂志, 2017, 19 (2) : 314-318.
|
| 19 |
DickerAJ, CrichtonML, PumphreyEG,et al.Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease[J].J Allergy Clin Immunol,2018,141 (1):117-127.
|
| 20 |
PandeyS, GargR, KantS,et al.Serum procalcitonin levels in chronic obstructive pulmonary disease patients in North Indian population[J].Ann Afr Med,2019,18 (2):103-107.
|